Carsten Haagen Nielsen

Medicine & Life Sciences

1. Factor VII 100%
2. Positron-Emission Tomography 98%
3. Thromboplastin 86%
4. Catalytic Domain 70%
5. Neoplasms 67%
6. 6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo(d)thiazol-2(3H)-one 60%
7. Vascular Calcification 40%
8. Gene Expression 37%
9. Uremia 37%
10. 64Cu-DOTA-rituximab 37%
11. Reporter Genes 34%
12. Positron Emission Tomography Computed Tomography 31%
13. Cystine-Knot Miniproteins 31%
14. Heterografts 30%
15. ependymins 30%
16. alovudine 30%
17. Transgenic Mice 30%
18. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 29%
19. Beige Adipose Tissue 26%
20. Genetic Therapy 26%
21. Peroxiredoxin VI 26%
22. Click Chemistry 25%
23. Molecular Imaging 24%
24. sigma-1 receptor 24%
25. Ligands 24%
26. White Adipocytes 23%
27. ICG 001 22%
28. CREB-Binding Protein 22%
29. Myocardium 22%
30. Fluorodeoxyglucose F18 22%
31. Fluorine-18 22%
32. Brown Adipocytes 22%
33. Bone Morphogenetic Protein 7 22%
34. Follicular Adenocarcinoma 22%
35. Azides 22%
36. Aorta 22%
37. Urokinase Plasminogen Activator Receptors 21%
38. Neodymium 21%
39. Oximes 21%
40. Firefly Luciferases 21%
41. Saimiri 21%
42. Raloxifene Hydrochloride 21%
43. 1,4,7-triazacyclononane-N,N',N''-triacetic acid 21%
44. Lung 20%
45. Neointima 20%
46. Injections 19%
47. Microbubbles 19%
48. Hypoxia-Inducible Factor 1 19%
49. Transgenes 19%
50. Catenins 19%